These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 20144066

  • 21. Add-on benefits of amlodipine and thiazide in nondiabetic chronic kidney disease stage 1/2 patients treated with valsartan.
    Kaneshiro Y, Ichihara A, Sakoda M, Kurauchi-Mito A, Kinouchi K, Itoh H.
    Kidney Blood Press Res; 2009; 32(1):51-8. PubMed ID: 19258723
    [Abstract] [Full Text] [Related]

  • 22. Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients.
    Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, Tamaki N, Tsutsui H.
    J Am Coll Cardiol; 2007 Sep 18; 50(12):1144-9. PubMed ID: 17868805
    [Abstract] [Full Text] [Related]

  • 23. The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy.
    Hoshino A, Nakamura T, Matsubara H.
    Clin Exp Hypertens; 2010 Sep 18; 32(7):416-22. PubMed ID: 20828223
    [Abstract] [Full Text] [Related]

  • 24. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study.
    Katayama S, Yagi S, Yamamoto H, Yamaguchi M, Izumida T, Noguchi Y, Inaba M, Inukai K.
    Hypertens Res; 2007 Jun 18; 30(6):529-33. PubMed ID: 17664856
    [Abstract] [Full Text] [Related]

  • 25. Olmesartan/Amlodipine: combination therapy for the treatment of hypertension [corrected].
    Pimenta E.
    Adv Ther; 2009 Jan 18; 26(1):1-11. PubMed ID: 19129998
    [Abstract] [Full Text] [Related]

  • 26. Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin-angiotensin-system inhibitors - a multicenter, open, randomized trial using 24-hour urine collection.
    Miwa Y, Tsuchihashi T, Ohta Y, Tominaga M, Kawano Y, Sasaguri T, Ueno M, Matsuoka H.
    Clin Exp Hypertens; 2010 Jan 18; 32(6):400-5. PubMed ID: 20828221
    [Abstract] [Full Text] [Related]

  • 27. Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension.
    Kato J, Yokota N, Tamaki N, Kariya S, Kita T, Ayabe T, Eto T, Kitamura K.
    Hypertens Res; 2011 Mar 18; 34(3):331-5. PubMed ID: 21124326
    [Abstract] [Full Text] [Related]

  • 28. Spironolactone and chlorthalidone in uncontrolled elderly hypertensive patients treated with calcium antagonists and angiotensin II receptor-blocker: effects on endothelial function, inflammation, and oxidative stress.
    Yamanari H, Nakamura K, Miura D, Yamanari S, Ohe T.
    Clin Exp Hypertens; 2009 Oct 18; 31(7):585-94. PubMed ID: 19886856
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.
    Oparil S, Weber M.
    Postgrad Med; 2009 Mar 18; 121(2):25-39. PubMed ID: 19332960
    [Abstract] [Full Text] [Related]

  • 30. Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats.
    Choi SM, Seo MJ, Kang KK, Kim JH, Ahn BO, Yoo M.
    Arch Pharm Res; 2009 Mar 18; 32(3):353-8. PubMed ID: 19387578
    [Abstract] [Full Text] [Related]

  • 31. Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.
    Matsuzaki M, Ogihara T, Umemoto S, Rakugi H, Matsuoka H, Shimada K, Abe K, Suzuki N, Eto T, Higaki J, Ito S, Kamiya A, Kikuchi K, Suzuki H, Tei C, Ohashi Y, Saruta T, Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group.
    J Hypertens; 2011 Aug 18; 29(8):1649-59. PubMed ID: 21610513
    [Abstract] [Full Text] [Related]

  • 32. Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker.
    Ichihara A, Kaneshiro Y, Sakoda M, Takemitsu T, Itoh H.
    J Cardiovasc Pharmacol; 2007 Mar 18; 49(3):161-6. PubMed ID: 17414228
    [Abstract] [Full Text] [Related]

  • 33. Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination.
    Kostis JB.
    Am J Ther; 2010 Mar 18; 17(2):188-96. PubMed ID: 19433970
    [Abstract] [Full Text] [Related]

  • 34. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar 18; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 35. One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney disease.
    Tomino Y, Shimizu Y, Hamada C, Kurusu A, Ohsawa I, Suzuki Y, Tsuge T, Io H, Kobayashi N, Takeda Y, Asanuma K, Tanaka Y, Suzuki H, Nakata J, Takara K, Horikoshi S.
    J Nephrol; 2011 Mar 18; 24(6):756-63. PubMed ID: 21360472
    [Abstract] [Full Text] [Related]

  • 36. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension.
    Watanabe S, Okura T, Kurata M, Irita J, Manabe S, Miyoshi K, Fukuoka T, Murakami K, Higaki J.
    Clin Ther; 2006 Oct 18; 28(10):1677-85. PubMed ID: 17157123
    [Abstract] [Full Text] [Related]

  • 37. ARB candesartan and CCB amlodipine in hypertensive patients: the CASE-J trial.
    Ogihara T, Fujimoto A, Nakao K, Saruta T, CASE-J Trial Group.
    Expert Rev Cardiovasc Ther; 2008 Oct 18; 6(9):1195-201. PubMed ID: 18939907
    [Abstract] [Full Text] [Related]

  • 38. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
    Kojima M, Taniguchi M, Sato K, Ueda R, Dohi Y.
    Nephron Clin Pract; 2004 Oct 18; 97(2):c49-53. PubMed ID: 15218330
    [Abstract] [Full Text] [Related]

  • 39. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 18; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 40. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study.
    Martinez-Martin FJ, Saiz-Satjes M.
    Expert Rev Cardiovasc Ther; 2008 Nov 18; 6(10):1347-55. PubMed ID: 19018688
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.